AO
TXG icon

Allen Operations’s 10x Genomics TXG Stock Holding History

Allen Operations’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-56,600
Closed -$1.28M – 32
2024
Q3 		$1.28M Hold
56,600
– – 0.22% 25
2024
Q2 		$1.1M Hold
56,600
– – 0.22% 25
2024
Q1 		$2.12M Hold
56,600
– – 0.4% 24
2023
Q4 		$3.17M Hold
56,600
– – 0.63% 22
2023
Q3 		$2.33M Hold
56,600
– – 0.52% 25
2023
Q2 		$3.16M Hold
56,600
– – 0.7% 23
2023
Q1 		$3.16M Hold
56,600
– – 0.8% 23
2022
Q4 		$2.06M Hold
56,600
– – 0.55% 23
2022
Q3 		$1.61M Buy
+56,600
New +$2.16M 0.43% 25

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Allen Operations's TXG Position: Q4 2024 in Review

Allen Operations sold out of 10x Genomics (TXG) in Q4 2024, closing a stake of 56,600 shares — an estimated $1.28M sold.

Allen Operations first reported a position in TXG in Q3 2022 and held it in 9 quarters. The position peaked at $3.17M in Q4 2023. 273 funds tracked by Wall St. Rank hold TXG as of Q4 2024.

  • Allen Operations reported no remaining 10x Genomics position as of Q4 2024 after selling out during the quarter.
  • Allen Operations sold 56,600 10x Genomics shares in Q4 2024, an estimated $1.28M.
  • Allen Operations first reported a position in 10x Genomics in Q3 2022 and held it in 9 quarters.
  • Allen Operations's 10x Genomics position peaked at $3.17M in Q4 2023.
  • 273 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2024.

Based on Allen Operations's 13F filing for Q4 2024, filed 10 Feb 2025.